TickerFacts.

Company research / LFVN

Lifevantage Corp (LFVN)

Build a valuation ↗↓ Download CSV

CIK 0000849146 · Nasdaq · Pharmaceutical Preparations

  • Sector Manufacturing
  • Fiscal year ends Dec 31

For the year ended 2026-06-30, Lifevantage Corp reported revenue of $182.59M. Revenue fell 20.1% from the prior annual period.

Key ratios (year ended 2026-06-30)

77.6%
Gross margin
3.3%
Operating margin
2.8%
Net margin
15.1%
Return on year-end equity
-20.1%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 4 (ownership change) · 2026-10-09

Headquarters locality: Salt Lake City · View on map

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

Stock splits: 1-for-7, first reflected in a filing dated 2015-11-04. Figures are as filed: per-share figures and share counts last reported before a split are on the old share basis, so changes and growth rates across a split are not shown. Splits are read from the filings' own restatements, so a share conversion in a merger or reorganization shows up the same way.

Period ended2026-06-302025-06-302024-06-302023-06-302022-06-302021-06-302020-06-302019-06-302018-06-302017-06-30
Revenue$182.59M$228.53M$200.16M$213.40M$206.36M$220.18M$232.91M$225.96M$203.20M$199.49M
Cost of Revenue$40.97M$44.86M$41.44M$43.39M$38.10M$38.19M$37.96M$37.97M$34.85M$33.46M
Gross Profit$141.61M$183.67M$158.72M$170.01M$168.26M$181.99M$194.95M$187.99M$168.36M$166.03M
R&D Expense$1.00M$1.40M$700.0K$600.0K$700.0K$700.0K$900.0K$1.10M$1.20M$1.10M
Operating Income$6.10M$12.20M$4.33M$4.26M$7.58M$17.61M$15.47M$9.81M$10.32M$4.45M
Depreciation & Amortization$2.77M$3.16M$3.58M$3.58M$3.26M$3.46M$2.78M$1.90M$1.32M$1.64M
EBITDA$8.87M$15.36M$7.91M$7.84M$10.84M$21.07M$18.24M$11.71M$11.65M$6.09M
Net Income$5.07M$9.80M$2.94M$2.54M$3.12M$12.89M$11.55M$7.43M$5.76M$1.61M
EPS (Diluted)$0.40$0.75$0.23$0.20$0.24$0.90$0.79$0.50$0.41$0.11
Total Assets$62.11M$71.96M$60.30M$66.12M$70.71M$78.73M$58.88M$55.27M$51.14M$45.25M
Total Liabilities$28.52M$37.32M$34.31M$31.47M$39.19M$41.92M$25.62M$28.07M$29.20M$30.72M
Shareholders' Equity$33.59M$34.64M$25.99M$34.65M$31.52M$36.81M$33.25M$27.20M$21.94M$14.53M
Cash & Equivalentsn/a$20.20M$16.89M$21.61M$20.19M$23.17M$22.14M$18.82M$16.65M$11.46M
Operating Cash Flow$10.24M$11.88M$12.20M$6.83M$7.96M$16.27M$18.33M$17.79M$13.26M$6.60M
Capital Expenditures$3.57M$1.37M$2.25M$3.07M$1.53M$3.74M$2.68M$2.51M$4.65M$1.05M
Free Cash Flow$6.67M$10.51M$9.95M$3.76M$6.43M$12.53M$15.64M$15.28M$8.61M$5.54M
Share Repurchases$2.04M$3.15M$6.43M$822.0K$8.83M$11.93M$5.41M$4.66M$1.50M$0
Dividends Paid$2.34M$2.07M$6.94M$1.59M$378.0K$0$0n/an/an/a
Shares Outstanding12.52M12.43M12.51M12.62M12.49M13.61M14.31M14.11M14.07M14.23M
Dividends Per Share$0.18$0.17$0.55$0.12$0.03n/an/an/an/an/a
Weighted Average Diluted Shares12.70M12.99M12.99M12.57M13.07M14.27M14.60M14.98M14.14M14.12M
EPS (Basic)$0.40$0.80$0.24$0.20$0.24$0.92$0.82$0.53$0.41$0.12

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView